Chrysalis BioTherapeutics, Inc. Company Profile, Contacts & Intelligence

Biotechnology Research2200 Market Street6 employeesFounded 2009
1 contact with email or phone data1 with email data1 with phone data
View verified contacts Compare competitors
Employees
6
Company source estimate
Reachable Contacts
1
Visible contacts with email or phone data
Contacts With Email
1
1 of 3 visible contacts
Departments
1
Mapped contact coverage

Chrysalis BioTherapeutics, Inc. Overview

Chrysalis BioTherapeutics, Inc. is a privately held biopharmaceutical company developing regenerative drugs that mimic the body’s natural signals to activate endothelial progenitor cells and stem cells to stimulate tissue repair and restore normal tissue function. Chrysalis BioTherapeutics was incorporated in Delaware in 2012 to develop innovative peptide therapeutics to save lives and improve life’s quality. Chrysalis’ lead drug candidate, TP508, was initially developed to accelerate healing of dermal and musculoskeletal injuries. It proved to be especially effective in promoting healing of diabetic foot ulcers in early human clinical trials and is under development as a treatment for mass casualty injuries and burns. Chrysalis has demonstrated that TP508 mitigates effects of radiation exposure. Chrysalis is therefore collaborating with US government agencies to develop TP508 as a nuclear countermeasure to combat acute and delayed radiation syndromes and to mitigate damaging effects of brain cancer radiation therapy.

Headquarters
2200 Market Street
Website
chrysbio.com
Industry
Biotechnology Research
Founded
2009
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Show more similar pages

Chrysalis BioTherapeutics, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

1 contact with contact data
1 with email data and 1 with phone data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
1 company-domain email
Visible contacts using Chrysalis BioTherapeutics, Inc.'s company email domain.
General
1

Chrysalis BioTherapeutics, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

T
Timothy Schmidt
Healthcare Executive - Cco - Head
R
Richard Sutton
Small Business Financial Consultant
L
Laurie Sower
Consultant
EP

Chrysalis BioTherapeutics, Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Individual contributor
3
Manager
1

Compare Similar Companies to Chrysalis BioTherapeutics, Inc.

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Kinea Bio Biotechnology Research 6 View company
Synovel Laboratory, LLC Pharmaceutical Manufacturing 6 View company
Xequel Bio Biotechnology Research 6 View company
Estrigenix Therapeutics, Inc. Pharmaceutical Manufacturing 4 View company
ResQ Pharma, Inc. Pharmaceutical Manufacturing 3 View company
Axiom Biopharma Biotechnology Research 1 View company
CitareTx Venture Capital And Private Equity Principals 1 View company
Hughes BioPharma Advisers LLC Clinical Operations Consulting Business Consulting And Services 1 View company
Perfinity Biosciences Biotechnology Research Not listed View company
PRUNUS Therapeutics Biotechnology Not listed View company